Clear Alpha Technologies LP Innoviva, Inc. Transaction History

Clear Alpha Technologies LP

  • $359 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$14.4 - $16.4 $70,286 - $80,048
-4,881 Reduced 16.5%
24,704 $405 Million
Q1 2024

May 13, 2024
SELL
$14.56 - $16.78 $26,251 - $30,254
-1,803 Reduced 5.74%
29,585 $451 Million
Q4 2023

Feb 12, 2024
BUY
$12.32 - $16.27 $386,700 - $510,682
31,388 New
31,388 $503 Million

Others Institutions Holding INVA

# of Institutions
227
Shares Held
78.9M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.23B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Clear Alpha Technologies LP Portfolio

Follow Clear Alpha Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Alpha Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Clear Alpha Technologies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email